Avantor, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Avantor, Inc. on July 15, 2021. The report discloses a corporate governance event regarding the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of John Carethers, M.D., as a Class III independent director. This appointment fills a vacant board seat. Dr. Carethers is the John G. Searle Professor and Chair of the Department of Internal Medicine at the University of Michigan Medical School.
Compensation and Governance Details
- Term: Initial term expires at the 2022 Annual Meeting of Stockholders.
- Independence: The Board determined Dr. Carethers meets NYSE independence standards.
- Compensation:
- Annual cash retainer of $75,000 (prorated for 2021).
- Restricted stock units (RSUs) valued at $200,000 (prorated for 2021).
- RSUs vest in full one year from the grant date, contingent on continued service.
Investor Verification Checklist
- Verify the exact number of RSUs granted based on the market price of AVTR stock on July 15, 2021.
- Confirm the specific vesting schedule and any performance conditions attached to the RSUs in the full exhibit.
- Review the Company's most recent 10-Q or 10-K for financial metrics not included in this 8-K.